Investigation Report on China Dydrogesterone Market, 2010-2019
|出版商||China Research and Intelligence||商品編碼||338984|
|出版日期||內容資訊||英文 20 Pages
|Dydrogesterone的中國市場 Investigation Report on China Dydrogesterone Market, 2010-2019|
|出版日期: 2015年09月07日||內容資訊: 英文 20 Pages||
Dydrogesterone作為新世代的孕甾酮，1961年由Abbott Biologicals B. V. (荷蘭) 開發，之後在全球150個國家的市場上市。中國2004年4月也獲認證。調查對象醫院的Dydrogesterone的銷售額，從2005年的400萬人民幣，到2014年的1億人民幣以上，以年複合成長率(CAGR)50％速度急速擴大。現在雖然只能由Abbott Biologicals B.V.供給產品，不過，由於中國國內不孕症的問題變得嚴重，及新加入企業的登場，今後預期將進一步成長。
According to statistics, over 90% of Chinese adult women suffer from different kinds of gynecological conditions to different degrees. And for married urban women, the TOP5 gynecological disorders are genital tract infections (42.9%), menstrual disorder (34.5%), dysmenorrheal (15.5%), pelvic tumor (3.9%) and genital deformity (1.1%). According to Infertility in China, one in eight couples suffers from infertility whose incidence rose from 1-2% in the 1970s to 10-15% in 2014. And it is estimated that 12.5% of women at childbearing age i.e. over 40 million people in China suffer from infertility. 25-37% of infertility is caused by women and over 30% of infertility patients are white collars with high income. According to experts, infertility will become the third health killer after cardiovascular disease and tumor.
As a new generation of progesterone, dydrogesterone of Abbott Biologicals B.V. (Netherland) has been marketed in over 150 countries since its debut in 1961. And it has got the recognition of Chinese obstetricians since it entered China in Apr. 2004.
According to CRI's market survey, dydrogesterone develops fast after entering China with sales value in sample hospitals rising from less than 4 million in 2005 to over 100 million in 2014 and CAGR during this period reaching 50%. Currently, only dydrogesterone of Abbott Biologicals B.V. (Netherland) is available in the Chinese market. As the incidence of gynecological conditions stays high, dydrogesterone enjoys great market potential with its efficacy. Dydrogesterone market in China is expected to grow in future and it is possible that newcomers might appear too.
Readers can get at least the following information through this report:
The author suggests the following groups of people purchase this report: